Anaptysbio (ANAB) Amortizatization of Intangibles (2020 - 2026)
Anaptysbio's (ANAB) quarterly Amortizatization of Intangibles came in at $3.0 million in Q3 2023, up 281.76% YoY from $784000.0 in Q3 2022, and up 37.1% on a QoQ basis from $2.2 million in Q2 2023.
Powered by 
Analysis
Anaptysbio (ANAB) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Anaptysbio (ANAB) has 2 years of Amortizatization of Intangibles data on file, last reported at $3.0 million in Q3 2023.
- Quarterly Amortizatization of Intangibles rose 281.76% year-over-year to $3.0 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $8.2 million (changed N/A YoY) and the FY2020 annual result came in at -$461000.0, down 117.51% from the prior year.
- Amortizatization of Intangibles climbed to $3.0 million in Q3 2023, from $2.2 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $3.0 million in Q3 2023 to a low of -$161000.0 in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.26 Bn | 131.41 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.83 Bn | 52.69 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.19 Bn | 31.88 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 678,000.00 |
| 10 | Anaptysbio | 1.62 Bn | 1.33 Bn | - | 480,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 480,000.00 |
| Dec 31, 2025 | 475,000.00 |
| Sep 30, 2025 | 470,000.00 |
| Jun 30, 2025 | 459,000.00 |
| Mar 31, 2025 | 460,000.00 |
| Dec 31, 2024 | 456,000.00 |
| Sep 30, 2024 | 452,000.00 |
| Jun 30, 2024 | 441,000.00 |
| Mar 31, 2024 | 442,000.00 |
| Dec 31, 2023 | 439,000.00 |
| Sep 30, 2023 | 434,000.00 |
| Jun 30, 2023 | 424,000.00 |
| Mar 31, 2023 | 427,000.00 |
| Dec 31, 2022 | 422,000.00 |
| Sep 30, 2022 | 419,000.00 |
| Jun 30, 2022 | 408,000.00 |
| Mar 31, 2022 | 411,000.00 |
| Dec 31, 2021 | 220,000.00 |
| Sep 30, 2021 | 500,000.00 |
| Jun 30, 2021 | 625,000.00 |